Mounjaro
Mounjaro
Treatment Summary
Mounjaro is a prescription injectable medication used to help adults with obesity or overweight achieve weight loss. Mounjaro binds to GLP-1 and GIP (Glucagon-like Peptide-1 and Gastric Inhibitory Polypeptide) receptors to regulate appetite and promote weight reduction. Additionally, it may contribute to improving cardiovascular health in obese or overweight adults at risk for heart disease. Effectiveness is maximized when combined with a low-calorie diet and regular exercise.
Mounjaro
Treatment Features
-
Administered as a subcutaneous injection once a week, offering convenience and sustained effects.
-
Helps stabilize blood sugar levels, benefiting patients with type 2 diabetes.
-
Reduces the risk of cardiovascular disease for obese patients and positively impacts heart health.
-
Stimulates both GLP-1 and GIP hormones to regulate appetite and induce weight loss. This dual action enables more effective weight management.
Mounjaro
Mechanism of Action
Mounjaro stimulates both GLP-1 and GIP hormones to regulate appetite in the brain and naturally reduce food intake. These hormones decrease hunger and prolong satiety, helping the body lose weight. Additionally, it regulates blood sugar levels, providing beneficial effects for patients with type 2 diabetes. The interaction of these two hormones reduces post-meal blood sugar spikes and decreases fat accumulation, leading to weight loss.
Mounjaro
Recommended For
-
People who need type 2 diabetes management
-
Obese individuals with a BMI of 30 or higher
-
Those seeking long-term weight management
-
People who need weight control and blood sugar regulation
-
Obese individuals at risk for cardiovascular disease
Mounjaro
Treatment Time
Treatment Time
5~7 minutes
Treatment Frequency
1 week
Recovery Time
Same day
Mounjaro
Treatment Process
Step 1
Consultation
Step 2
Mounjaro Prescription
Mounjaro
Treatment Areas
Abdomen, thighs, arms
Mounjaro
Precautions
- It is prohibited for use during pregnancy and should only be used during breastfeeding after consulting a doctor.
- Patients with kidney disease should consult a doctor before use and monitor kidney function during treatment.
- May cause gastrointestinal side effects such as nausea, vomiting, and diarrhea. If symptoms worsen, discontinue use and consult a doctor.
- Symptoms such as abdominal pain, vomiting, and fever may indicate acute pancreatitis. In this case, stop using immediately and seek medical advice.
- Since it regulates blood sugar levels, hypoglycemia may occur, especially when used with diabetes medications like insulin. Immediate action is required if hypoglycemic symptoms appear.
FAQ
Mounjaro is administered as a subcutaneous injection once a week. The injection can be given in areas such as the abdomen, thighs, or upper arms. It is recommended to rotate injection sites each week to avoid using the same area repeatedly.
Results may vary by individual, but clinical trials have shown that weight loss typically begins within 2 weeks. Maximum effects may be seen around 3 months.
The most common side effects are gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation. Most side effects are temporary, but if unusual symptoms occur, consult a healthcare professional immediately.